WASHINGTON (Reuters) - Senators trying to promote human stem cell research rebuked a team of corporate scientists on Wednesday, saying their claims to have produced human embryonic stem cells without harming the embryo had misrepresented their work and hurt the cause.
Last month, the team at Advanced Cell Technology in Massachusetts said they had taken single cells from days-old embryos and used them to produce batches, or lines, of stem cells.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
